Is Portola Pharmaceuticals Inc. (NASDAQ:PTLA) worth grabbing?

1184

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) stock had a weekly volatility of 4.12% and a monthly volatility of 3.83%. Portola Pharmaceuticals, Inc. PTLA shares float stands at 55.54M.

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction. Longer term, the trend strength is Minimum.

Recently, Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) reported that Portola Pharmaceuticals, Inc. quarterly Return on Assets is -69.80%, while quarterly Return on Equity was -108.10% and quarterly Return on Investment was -112.00%.

The firm’s Total Debt/Equity stood at 0.61 while Long Term Debt/Equity was 0.61.

The firm’s stock 50-Day High is $-12.54% and a 50-Day Low of $6.13%. 20-Day Simple Moving Average was $-4.39% while 50-Day SMA was $-3.59%.

The firm announced EPS of $-4.35. This shows an EPS growth quarter over last quarter was 36.10%%. EPS for the year was $-9.30%. For the last 5-year, the stock has recorded EPS growth for imminent year is projected to be 37.20%.

The firm’s monthly average volume for the reported quarter was 774.99K and 774.99K for the full fiscal year. The relative volume was 0.83 for the quarter and 0.83 for the full fiscal year.

The stock’s 50-Day High in the last quarter was $-12.54% while the 50-Day Low was $6.13%. In the last fiscal year, the stock hit a 52-Week High of $-12.54% and a 52-Week Low of $138.39%.

The firm’s insider ownership was 0.10% and institutional ownership was 91.70%. Total institutional transactions amounted to -0.22%. Sales growth QoQ was -38.60%.

Portola Pharmaceuticals Inc. (NASDAQ:PTLA) announced that preclinical and clinical data on cerdulatinib in relapsed/refractory b-cell malignancies will be presented at the European Hematology Association (EHA), which is taking place from June 22-25 in Madrid, Spain.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.